Free Trial

Parr Mcknight Wealth Management Group LLC Invests $11.86 Million in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Parr Mcknight Wealth Management Group LLC acquired a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 23,454 shares of the healthcare conglomerate's stock, valued at approximately $11,864,000. UnitedHealth Group makes up about 1.7% of Parr Mcknight Wealth Management Group LLC's investment portfolio, making the stock its 8th biggest holding.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Waycross Partners LLC boosted its position in UnitedHealth Group by 2.4% during the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock valued at $14,060,000 after acquiring an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $515,000. Full Sail Capital LLC boosted its position in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth $39,413,000. Finally, Silvercrest Asset Management Group LLC boosted its position in shares of UnitedHealth Group by 47.8% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate's stock worth $19,625,000 after purchasing an additional 12,550 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Down 2.2%

NYSE:UNH opened at $296.45 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock's fifty day moving average is $456.57 and its two-hundred day moving average is $506.94. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The stock has a market capitalization of $268.92 billion, a price-to-earnings ratio of 19.13, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 2.83%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's payout ratio is 35.18%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on UNH shares. Barclays dropped their price target on UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating on the stock in a research note on Thursday, May 15th. Morgan Stanley reduced their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Raymond James lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Finally, HSBC reiterated a "reduce" rating and set a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday. One analyst has rated the stock with a sell rating, six have given a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and a consensus price target of $441.87.

Get Our Latest Analysis on UnitedHealth Group

Insiders Place Their Bets

In related news, CFO John F. Rex purchased 17,175 shares of the stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the acquisition, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of UnitedHealth Group stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is currently owned by insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines